RemeGen Statistics

Total Valuation

RemeGen has a market cap or net worth of HKD 59.85 billion. The enterprise value is 60.97 billion.

Market Cap	59.85B
Enterprise Value	60.97B

Important Dates

The next confirmed earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

RemeGen has 556.51 million shares outstanding. The number of shares has increased by 2.12% in one year.

Current Share Class	200.81M
Shares Outstanding	556.51M
Shares Change (YoY)	+2.12%
Shares Change (QoQ)	+1.59%
Owned by Insiders (%)	11.98%
Owned by Institutions (%)	26.21%
Float	337.07M

Valuation Ratios

The trailing PE ratio is 59.42 and the forward PE ratio is 39.95.

PE Ratio	59.42
Forward PE	39.95
PS Ratio	16.54
PB Ratio	23.18
P/TBV Ratio	24.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	77.32
EV / Sales	16.85
EV / EBITDA	57.52
EV / EBIT	75.94
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.94
Debt / EBITDA	2.29
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 32.91% and return on invested capital (ROIC) is 21.69%.

Return on Equity (ROE)	32.91%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	21.69%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.91%
Revenue Per Employee	1.21M
Profits Per Employee	262,905
Employee Count	3,070
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RemeGen has paid 833,161 in taxes.

Income Tax	833,161
Effective Tax Rate	0.11%

Stock Price Statistics

The stock price has increased by +402.95% in the last 52 weeks. The beta is 0.72, so RemeGen's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+402.95%
50-Day Moving Average	83.37
200-Day Moving Average	79.27
Relative Strength Index (RSI)	56.44
Average Volume (20 Days)	2,969,229

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RemeGen had revenue of HKD 3.62 billion and earned 788.45 million in profits. Earnings per share was 1.44.

Revenue	3.62B
Gross Profit	3.62B
Operating Income	802.82M
Pretax Income	789.29M
Net Income	788.45M
EBITDA	1.06B
EBIT	802.82M
Earnings Per Share (EPS)	1.44

Full Income Statement

Balance Sheet

The company has 1.31 billion in cash and 2.43 billion in debt, giving a net cash position of -1.12 billion or -2.01 per share.

Cash & Cash Equivalents	1.31B
Total Debt	2.43B
Net Cash	-1.12B
Net Cash Per Share	-2.01
Equity (Book Value)	2.58B
Book Value Per Share	4.67
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 22.19% and 21.79%.

Gross Margin	100.00%
Operating Margin	22.19%
Pretax Margin	21.82%
Profit Margin	21.79%
EBITDA Margin	29.30%
EBIT Margin	22.19%
FCF Margin	n/a

Dividends & Yields

RemeGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.12%
Shareholder Yield	-2.12%
Earnings Yield	1.32%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2